Ravi Vij, MD | Authors


Monoclonal Antibodies for the Treatment of Patients With Multiple Myeloma

July 31, 2015

Ravi Vij, MD, associate professor of medicine, Division of Oncology, Section of Bone Marrow Transplant, Washington University School of Medicine, discusses the monoclonal antibody daratumumab for the treatment of patients with heavily pretreated multiple myeloma.